Here’s a concise overview of the applications of **Cefditoren Pivoxil** in English:
---
### **Cefditoren Pivoxil: Key Applications**
#### **1. Drug Profile**
- **Class**: Third-generation **oral cephalosporin** (β-lactam antibiotic).
- **Prodrug**: Converts to active **cefditoren** in the body.
- **Spectrum**: Broad activity against **Gram-positive** and some **Gram-negative** bacteria.
---
### **2. Clinical Uses**
#### **✅ Respiratory Infections**
- **Community-acquired pneumonia (CAP)**
- **Acute bronchitis**
- **Chronic bronchitis exacerbations**
- **Tonsillitis/Pharyngitis/Sinusitis**
#### **✅ Skin & Soft Tissue Infections**
- **Impetigo, Cellulitis**
- **Abscesses, Folliculitis**
#### **✅ Urinary Tract Infections (UTIs)**
- **Uncomplicated cystitis**
- **Gonorrhea** (limited to susceptible strains)
#### **✅ Ear, Nose, Throat (ENT) Infections**
- **Acute bacterial otitis media**
- **Bacterial sinusitis**
---
### **3. Antibacterial Spectrum**
✔ **Covers**:
- **Gram-positive**: *S. pneumoniae*, *S. aureus* (MSSA).
- **Gram-negative**: *H. influenzae*, *M. catarrhalis*, *E. coli*.
- **Anaerobes**: *Peptostreptococcus* spp.
✖ **Ineffective Against**:
- *Pseudomonas aeruginosa*, *Enterococci*, **MRSA**.
---
### **4. Dosage & Safety**
- **Adults**: 200 mg twice daily (adjust for renal impairment).
- **Contraindications**:
- Cephalosporin allergy.
- Severe kidney disease (dose adjustment needed).
- **Side Effects**:
- Common: Diarrhea, nausea, rash.
- Rare: Liver enzyme elevation, *C. difficile* infection.
- **Drug Interactions**:
- **Antacids** (reduce absorption; separate by 2 hours).
- **Probenecid** (may increase blood levels).
---
### **5. Available Brands**
- **Global**: *Spectracef* (US), *Meiact* (Japan).
- **China**: *Mei Ai Ke*
---
### **6. Summary**
Cefditoren pivoxil is a **versatile oral antibiotic** for mild-to-moderate bacterial infections (respiratory, skin, UTIs). It offers **convenient dosing** but requires caution in **allergy-prone patients** and with **concurrent medications**.
**Need details on specific infection guidelines or resistance patterns?**